Side-by-side view of 12 European MedTech markets on the dimensions that actually matter when prioritising your launch sequence — market size, regulator, hospital procurement model, language, reimbursement pathway, and tender calendar.
| Dimension | 🇩🇪 Germany | 🇬🇧 UK | 🇫🇷 France | 🇮🇹 Italy | 🇪🇸 Spain | 🇳🇱 NL | 🇨🇠CH | 🇧🇪 BE | 🇦🇹 AT | 🇵🇱 PL | 🇮🇪 IE | 🇵🇹 PT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MedTech market size | €34B | £8.5B | €17B | €11B | €8.5B | €5B | €7B | €3B | €2.5B | €3B | €1.2B | €1.5B |
| Regulator | BfArM | MHRA | ANSM | Min. Salute | AEMPS | IGJ | Swissmedic | FAMHP | BASG | URPL | HPRA | INFARMED |
| CE / UKCA / CH-REP | CE (EU MDR) | UKCA + CE temp | CE (EU MDR) | CE | CE | CE | CE + CH-REP | CE | CE | CE | CE | CE |
| Procurement model | Decentralized + Einkaufsgem. | NHS Supply Chain | UniHA / GHT | Regional ESTAR/ARIA | Regional Servicios | Intrakoop / UMCs | Hospital + cantonal | Mercurhosp | BBG + Länder | NFZ tender | HSE central | SPMS |
| Reimbursement | DRG + Hilfsmittelverz. | NICE-driven | LPP + HAS | Regional formularies | AEMPS Catálogo | ZIN HTA | SwissDRG | RIZIV/INAMI | SVK | NFZ | HSE | SPMS |
| Language(s) | German | English | French | Italian | Spanish | Dutch | DE/FR/IT | NL/FR/DE | German | Polish | English | Portuguese |
| Hospital concentration | Medium | Very high (NHS) | High (GHT) | Medium (regional) | High (regional) | High (alliances) | Low (cantonal) | Medium | Medium (Länder) | High (voivod.) | Very high (HSE) | High (SPMS) |
| Tender intensity | Medium | High | Very high | High | Medium | Medium | Low | Medium | Medium | Very high | High | High |
| Typical distributor margin | 25-40% | 20-35% | 25-40% | 30-45% | 30-45% | 25-40% | 20-35% | 25-40% | 25-40% | 30-50% | 20-35% | 30-45% |
| Speed to first sale | 9-18 mo | 9-15 mo | 12-24 mo | 9-18 mo | 9-18 mo | 6-12 mo | 6-12 mo | 6-12 mo | 6-12 mo | 12-18 mo | 9-15 mo | 6-12 mo |
| Country hub | View → | View → | View → | View → | View → | View → | View → | View → | View → | View → | View → | View → |
Tier-1 markets (highlighted) — Germany and France — are the two essential European markets for any serious launch. Germany for absolute revenue, France for the centralized procurement model that, once you're in, gives you systematic hospital reach.
"Speed to first sale" is a rough range based on average market entry timelines for distributor-led launches in our experience. It assumes regulatory documentation is ready and a distributor has been signed. France is slower because of HAS / GHT processes; Switzerland, Benelux and Portugal are faster because hospital procurement is less centralized.
"Tender intensity" indicates how price-driven and formal the public hospital procurement is. High = public tendering dominates, distributor relationships matter less than tender capability. Low = relationship and KOL access carry more weight.
Publish one product or a coherent product family for €200 including VAT, for 90 days from publication. One-off payment, with no automatic renewal. Pay securely after submitting your ad. We review within 1–2 business days; unpublished ads are refunded in full.
Post a product opportunityBrowse opportunities for freeDistributors contact advertisers directly for free. Publication does not include outreach, introductions or guaranteed responses or sales.
Bespoke advisory by Fractio
For brands and distributors seeking focused support with market priorities, distribution strategy or sales direction. Scope, fees and deliverables are agreed in a separate proposal.
Discuss your commercial priorities →